Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 685 of 1,261

  1. US 9388104

    Chemically modified small molecules

    Nektar Therapeutics · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  2. US 9388159

    Substituted diazaspiroalkanes as androgen receptor modulators

    The Regents of the University of California · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  3. US 9387245

    Methods and compositions for the inhibition of fructokinase

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  4. US 9387249

    Methods of treating hypertension with at least one angiotensin II receptor blocker and chlorthalidone

    Takeda Pharmaceutical Company Limited · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  5. US 9388222

    Modified Pseudomonas exotoxin A

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  6. US 9388163

    Multifunctional radical quenchers for the treatment of mitochondrial dysfunction

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  7. US 9388145

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  8. US 9387224

    Treatment of specific cardiovascular conditions with nitrite

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  9. US 9388195

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  10. US 9382536

    Antisense antiviral compounds and methods for treating a filovirus infection

    Sarepta Therapeutics, Inc. · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted

  11. US 9381180

    Compositions and methods for treating chronic inflammation and inflammatory diseases

    Infirst Healthcare Limited · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted

  12. US 9382256

    Formulation of Syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted

  13. US 9382213

    Heterocyclic and cyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase

    UNIVERSITY OF CONNECTICUT · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted

  14. US 9381236

    Interferon-β production modulating listeria strains and methods for using same

    The Regents of the University of California · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted

  15. US 9381185

    Methods of inducing sedation

    The Regents of the University of California · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted

  16. US 9382188

    Aromatic ring compound

    Takeda Pharmaceutical Company Limited · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted

  17. US 9381202

    Salts of potassium ATP channel openers and uses thereof

    ESSENTIALIS, INC. · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted

  18. US 9381228

    FKBP-L and uses thereof

    ALMAC DISCOVERY LIMITED · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted

  19. US 9382200

    Process for the preparation of and crystalline forms of optical enantiomers of modafinil

    Teva Sante · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted

  20. US 9382547

    Human optimized Bacillus anthracis protective antigen

    United States of America as represented by the Secretary of the Air Force · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted

  21. US 9382327

    Anti-CD20 antibodies and methods of use

    VACCINEX, INC. · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted

  22. US 9382302

    Lutzomyia longipalpis polypeptides and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted

  23. US 9382317

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted

  24. US 9382311

    HIV-1 broadly neutralizing antibodies

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.